Gateway 2011: Baxter BioPharma Solutions - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Baxter BioPharma Solutions


Baxter Healthcare Corporation
25212 W. Illinois Route 120
Round Lake, IL 60073
Telephone: 800.422.9837 (US), 847.948.4770 (Outside US)
Fax: 847.948.3642
E-mail: biopharmasolutions@baxter.com
Website: baxterbiopharmasolutions.com
Number of Employees: 49,700 globally
Date Founded: 1931

BioPharma Solutions, a business unit of Baxter, partners with pharmaceutical companies to support your commercialization objectives by providing scientific expertise, sterile manufacturing solutions, parenteral delivery systems, and customized support services needed to meet the unique challenges that parenteral products face.

Experience Makes the Difference. With 80 years of parenteral expertise, we can help to navigate the pathway of success for your molecule. Our long-standing history puts unique expertise at your fingertips.

We Understand Parenterals. As a parenterals specialist, BioPharma Solutions offers unique delivery systems and a wide variety of manufacturing solutions to meet complex and traditional sterile manufacturing challenges. In addition, we offer a broad spectrum of support services including formulation and development to help solve the highstakes challenges in today’s complex parenteral marketplace. Our areas of expertise include:

Parenteral Delivery Systems

  • Prefilled Syringes
  • Liquid Vials
  • Lyophilized Vials
  • Cartridges
  • Frozen Premix Systems
  • Liquid Premix Systems
  • BIO-SET Luer System
  • Diluents for Reconstitution
  • Ampoules
  • Powder Filled Vials
  • Sterile Crystallization

Drug Categories

  • Small Molecules
  • Biologics; including Monoclonal Antibodies and Therapeutic Proteins
  • Vaccines; both Adjuvant and Conjugate
  • Cytotoxics
  • Antibody-Drug Conjugates (ADCs)
  • Highly Potent Compounds
  • Cephalosporins/Penicillins

Extensive Network. With more than 50 manufacturing facilities across six continents, Baxter’s global presence provides opportunities for unique manufacturing collaborations to provide the most value for our partners. The power of an extensive global network lies in the coordination of, and efficiencies resulting from, a systemic approach to cGMP manufacturing.

We Take Partnering Seriously. As a partner to over 60 pharmaceutical clients, we realize that successful alliances are critical in this extremely competitive environment. BioPharma Solutions has developed strong organizational capabilities to ensure our partnership provides the value you deserve and expect. Because of this we have been honored with various global distinctions by the industry including “Best Contract Manufacturing Organization” at the Vaccine Industry Excellence Awards and European Outsourcing Award winner for Most Effective Scaleup/Technical Transfer, to name a few.

Ultimately, our goal is to make you feel confident and secure choosing BioPharmaSolutions as a partner—helping you to avoid the unexpected and guiding you through marketplace complexities so you can achieve the full potential of your molecule.

BioPharma Solutions provides our clients with confidence of delivery, service, and integrity—we know the work we do is ultimately vital to the patients you serve.

*Baxter and Bio-Set are registered trademarks of Baxter International Inc., its subsidiaries or affiliates.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
43%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
14%
Raw material supply problems
14%
Regulatory restrictions
0%
Business decisions to limit production
29%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced

Click here